The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
Clinical trial NCT00090116 · COMPLETED
Trial details
- NCT number
- NCT00090116
- Sponsor
- Forest Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2005-03-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.